Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses

J Cardiovasc Pharmacol. 2018 Jan;71(1):10-18. doi: 10.1097/FJC.0000000000000538.

Abstract

Propofol blocks the voltage-gated human Kv1.5 (hKv1.5) channel by preferentially affecting in its open state. A previous mutational study suggested that several amino acids within the pore region of the hKv1.5 channel are involved in mediating the blocking action of propofol. The present investigation was undertaken to elucidate the predicted binding modes of propofol within the pore cavity of the open-state hKv1.5 channel, using computational docking and mutagenesis approaches. The docking simulation using a homology model of the hKv1.5 channel, constructed based on the crystal structure of the Kv1.2 channel, predicted that propofol was positioned at the base of the pore cavity of hKv1.5 channel, adjacent to 4 amino acids Thr479, Thr480, Val505, and Ile508, and formed arene-H interactions with Val505. The patch-clamp experiments on wild-type and mutant hKv1.5 channels constructed by site-directed mutagenesis revealed that the blocking potency of propofol was significantly reduced in T480A, V505A, and I508A but not in T479A mutants compared with wild-type hKv1.5 channel. These computational docking and experimental mutational analyses suggest that propofol is positioned at the base of the pore cavity and forms functional contact with Thr480, Val505, and Ile508 to directly block the hKv1.5 channel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • CHO Cells
  • Cricetulus
  • Humans
  • Ion Channel Gating / drug effects*
  • Kv1.5 Potassium Channel / antagonists & inhibitors*
  • Kv1.5 Potassium Channel / chemistry
  • Kv1.5 Potassium Channel / genetics
  • Kv1.5 Potassium Channel / metabolism
  • Membrane Potentials / drug effects
  • Molecular Docking Simulation*
  • Mutagenesis, Site-Directed*
  • Mutation
  • Potassium Channel Blockers / chemistry
  • Potassium Channel Blockers / metabolism
  • Potassium Channel Blockers / pharmacology*
  • Propofol / chemistry
  • Propofol / metabolism
  • Propofol / pharmacology*
  • Protein Binding
  • Protein Conformation
  • Structure-Activity Relationship

Substances

  • KCNA5 protein, human
  • Kv1.5 Potassium Channel
  • Potassium Channel Blockers
  • Propofol